Evidence map›Paper›PMID 40548935›Full record

ArticleNucleic acids research2025

PglZ from Type I BREX phage defence systems is a metal-dependent nuclease that forms a sub-complex with BrxB.

Jennifer J Readshaw, Lindsey A Doyle, Maria Puiu, Abigail Kelly, Andrew Nelson, Alex J Kaiser, Sydney F McGuire, Julieta Peralta Acosta, Darren L Smith, Barry L Stoddard and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jennifer J ReadshawDepartment of Biosciences, Durham University, Stockton Road, DurhamDH1 3LE, UK.
Lindsey A DoyleDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N. Seattle WA 98019, United States.ORCID 0000-0002-0008-473X
Maria PuiuDepartment of Biosciences, Durham University, Stockton Road, DurhamDH1 3LE, UK.
Abigail KellyDepartment of Biosciences, Durham University, Stockton Road, DurhamDH1 3LE, UK.
Andrew NelsonDepartment of Applied Sciences, University of Northumbria, Newcastle Upon Tyne NE1 8ST, UK.
Alex J KaiserDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N. Seattle WA 98019, United States.
Sydney F McGuireDepartment of Biology, Seattle University, 901 12th Ave. Seattle WA 98122, United States.
Julieta Peralta AcostaDepartment of Biology, Seattle University, 901 12th Ave. Seattle WA 98122, United States.
Darren L SmithDepartment of Applied Sciences, University of Northumbria, Newcastle Upon Tyne NE1 8ST, UK.ORCID 0000-0003-4925-467X
Barry L StoddardDivision of Basic Sciences, Fred Hutchinson Cancer Center, 1100 Fairview Ave. N. Seattle WA 98019, United States.ORCID 0000-0001-5174-7858
Brett K KaiserDepartment of Biology, Seattle University, 901 12th Ave. Seattle WA 98122, United States.
Tim R BlowerDepartment of Biosciences, Durham University, Stockton Road, DurhamDH1 3LE, UK.ORCID 0000-0002-7390-6458

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
MegaTALS: hyperspecific reagents for targeted gene modification and correctionR01GM105691 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2014 to 2022
$2.7M
Biophysical and structural studies of protein and enzyme mechanism, evolution, and engineeringR35GM148166 · NIGMS · FRED HUTCHINSON CANCER CENTER · PI BARRY L. STODDARD · 2023 to 2026
$2.3M
Characterization of the Bacterial BREX Phage Restriction System - Administrative SupplementR15GM140375 · NIGMS · SEATTLE UNIVERSITY · PI Brett Kian Kaiser · 2021 to 2026
$919k
Biotechnology and Biological Sciences Research Council BB/T008695/1BKK R15GM140375Fred Hutchinson Cancer CenterLister Institute Prize Fellowship to A.K. and T.R.B.NCI NIH HHS P30 CA015704New England BiolabsNIGMS NIH HHS R01 GM105691NIGMS NIH HHS R01 GM129325NIGMS NIH HHS R15 GM140375NIGMS NIH HHS R35 GM148166NIH HHS R01GM105691NIH HHS R35GM148166responsive mode BB/Y003659/1
6 · The paper itself

Abstract

BREX (Bacteriophage Exclusion) systems, identified through shared identity with Pgl (Phage Growth Limitation) systems, are a widespread, highly diverse group of phage defence systems found throughout bacteria and archaea. The varied BREX Types harbour multiple protein subunits (between four and eight) and all encode a conserved putative phosphatase, PglZ, and an equally conserved, putative ATPase, BrxC. Almost all BREX systems also contain a site-specific methyltransferase, PglX. Despite having determined the structure and fundamental biophysical and biochemical behaviours of several BREX factors (including the PglX methyltransferase, the BrxL effector, the BrxA DNA-binding protein, and a commonly-associated transcriptional regulator, BrxR), the mechanism by which BREX impedes phage replication remains largely undetermined. In this study, we identified a stable BREX sub-complex of PglZ:BrxB, generated and validated a structural model of that protein complex, and assessed the biochemical activity of PglZ from BREX, revealing it to be a metal-dependent nuclease. PglZ can cleave cyclic oligonucleotides, linear oligonucleotides, plasmid DNA and both non-modified and modified linear phage genomes. PglZ nuclease activity has no obvious role in BREX-dependent methylation, but does contribute to BREX phage defence. BrxB binding does not impact PglZ nuclease activity. These data contribute to our growing understanding of BREX phage defence.

Indexed as

Bacterial ProteinsBacteriophagesDNA-Binding ProteinsViral ProteinsMetalsModels, MolecularBacterial ProteinsDNA-Binding ProteinsMetalsViral Proteins

Identifiers

PMID40548935
PMCPMC12205998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.